Newanthracycline antibiotics, identified as e-rhodomycinone glycosides, were isolated from the culture broth of a blocked mutant of /?-rhodomycin-producing Streptomyces violaceus A262. They were designated as epelmycins A, B, C, D and E, and assayed for their in vitro cytotoxicities against murine leukemic L1210 cell culture and the antimicrobial activities in comparison with known anthracycline antibiotics.
In a preceding paper1*, we described the mutational derivation of antibiotic-blocked mutants and variant strains from Streptomyces violaceus A262 which produced known diglycosidic /?-rhodomycins, A262-1, A262-2, and A262-3. One of these, strain SU2-730, was found to produce new e-rhodomycinone glycosides in the absence of parental /?-rhodomycins. Two families of anthracycline antibiotics with a 10-methoxycarbonyl group are known, the aclacinomycins2) and the cinerubins (1-hydroxyaclacinomycins)3).
However, a microbial strain producing either ll-hydroxyaclacinomycins or 1,ll-hydroxyaclacinomycins has not been obtained until now.
In this paper, we describe the 1 1-hydroxyaclacinomycins (s-rhodomycinone glycosides), designated as epelmycins4), which were produced by a blocked mutant derived from the /?-rhodomycin-producing S. violaceus A262 and their biological activities.
Materials and Methods

Microorganisms
The epelmycin-producing strain SU2-730 was isolated from S. violaceus A262 as previously described1*, cultivated at 28°C on YS agar slant (yeast extract 0.3%, soluble starch 1.0% and agar 1.5%, pH 7.2) and then stored at 5°C. This strain was deposited as FERMP-8166 in Fermentation Research Institute, Agency of Industrial Science and Technology.
Fermentation
Seed cultures were grown aerobically at 28°C for 48 hours in 500-ml Erlenmeyer flasks containing Presentaddress: t Showa Pharmacochemical Co., Ltd., 1-16-5 Kyobashi, Chuo-ku, Tokyo 104, Japan. tf Faculty of Applied Biological Science, Hiroshima University, 1-4-4 Kagamiyama, Higashihiroshima 724, Japan.
100ml ofa following medium; soluble starch 0.5%, glucose 0.5%, soybean meal 1.0%, yeast extract 0.1%, NaCl 0.1%, K2HPO4 0.1%, MgSO4à"7H2O0.1%, pH 7.4, and were used as inoculum (5%) for two 30-liter jar fermenters each containing 15liters of fermentation medium which contained soluble starch 50g, soybean meal 30g, yeast extract 2g, NaCl 2g, CaCO3 2g, CuSO4-5H2O 0.01 g, FeSO4-7H2O 0.0016g, ZnSO4-7H2O 0.0032g, MnCl2-4H2O 0.013g in 1,000ml of tap water, pH 7.0. Fermentation conditions were 15 liters/minute for aeration and 300 rpm for agitation. The cultivation was carried out at 28°C for 130hours when the mycelial red pigments were produced at a maximum. About 30liters of the culture broth was prepared for the isolation of purified epelmycins.
Biological Activity
In vitro cytotoxicitiy and inhibition of DNAand RNAsyntheses in cells of murine leukemia L1210 were assayed according to the method previously described5). Antimicrobial activity was assayed by a standard broth dilution method*.
Qualitative Determination of Aglycone and Sugars by TLC Epelmycin in 0.1 n HC1(lOmg/ml) was heated at 85°C for 30minutes in a water bath. The aglycone thus obtained was extracted with CHC13.The CHC13layer was evaporated to dryness in vacuo and the red pigment residue was then purified by preparative TLC on Silica gel plate PF254 (E. Merck) using a developing solvent of CHC13 -MeOH(20 : 1). The purified aglycone was subjected to TLC on Silica gel F254 (E. Merck) using a developing solvent of CHC13 -MeOH (20 : 1).
Alternatively, the aqueous layer containing sugar components was neutralized by adding silver carbonate with a small amount of charcoal and centrifuged. The supernatant fluid was concentrated in vacuo and subjected to TLC on Silica gel plate F254 using a developing solvent of BuOH-acetic acid -H2O (4 : 1 : 1). The sugar spots were detected by spraying with^-anisaldehyde -H2SO4 (each 5%) in 90%EtOH and heating at 90°C. Aclarubicin, aclacinomycin B and MA144-N12)were also hydrolyzed in the same 
Mild Acid Hydrolysis
Epelmycin was partially hydrolized by standing a solution of 1 mg/ml in 0. 1 n HC1 at room temperature for 1 hour. After being alkalified to pH 8.0 with 0.1 n NaOH, the hydrolysate was extracted with CHC13 and the organic layer was evaporated in vacuo to dryness. The red pigment residue was subjected to TLC on Silica gel plate F254 using a developing solvent of CHC13 -MeOH (15 : 1).
HPLCAnalysis
To check the purity of products from the isolation and purification processes, HPLCwas performed on a Hitachi 655 liquid chromatographic apparatus with a reverse phase analytical column, juBondapak phenyl (3.9 x 300mm) (Waters Associates). Acetonitrile -0.04m ammonium formate (pH 3.0, 60 : 40) was used as a mobile phase and run at a flow rate of 1.5ml/minute. Samples were dissolved in the mobile phase and 10/zl samples injected. Detection was at 254nm using a UVdetector (UVILOG-5IIIA, Oyo-Bunko Kiki Co., Ltd.).
General
MP's were determined on a Kofler hotstage microscope. UVspectra were determined on a Hitachi EPS 3T and IR spectra (KBr pellet) on a Hitachi EPI-GS spectrophotometer.
*H and 13C NMRwere recorded with a Jeol GX-400spectrometer at 400 MHzand 100 MHz, respectively. Chemical shifts are expressed in S values (ppm) with TMSas an internal reference and coupling constants are given in / (Hz). Mass spectra were recorded with a Hitachi M-80Hspectrometer. Specific rotations were determined on a Jasco DIP-181 Digital Polarimeter. 
Isolation and Purification of Epelmycins
The fermentation broth (30 liters) was collected from two runs of a 30-liter jar fermentations and filtered, and the anthracycline products were extracted from the mycelial cake with a total of 10liters of acetone. The acetone extract was evaporated in vacuo to about 2 liters. The concentrate was extracted with 3liters of CHC13after being adjusted to pH 8.0 with 4n NaOH. The CHC13extract was evaporated in vacuo to a small volumeand an excess ofw-hexanewas added to precipitate the crude mixture ofanthracycline products. This isolation procedure provided about 7.6g of red crude powder, which could be resolved into five red components by chromatography on Silica gel plate F254 using a solvent mixture of CHC13-MeOH(8 : 1). The crude powder was chromatographed on a column of silica gel (Wakogel C-200) which was developed with solvent mixtures of CHC13-MeOH(in the order, stepwise, 100 : 1, 100 : 3 and 100 : 5) which eluted epelmycins in the following order B, A, E, C and D. Each compound was further purified by preparative TLC using a solvent mixture ofCHC13 -MeOH-aqueous NH3(120 : 10 : 0.2). Each epelmycin band on the TLCplate was removed and extracted with CHC13-MeOH(8 : 1). The extract was evaporated to dryness. The antibiotics recovered were dissolved in 20ml of 0.1 m acetate buffer (pH 3.5) and washed with 10ml of toluene. The aqueous layer was adjusted to pH 7.5 by addition of saturated aqueous NaHCO3and extracted with CHC13. The CHC13layer was washed with H2Oand concentrated after being dried over Na2SO4. An excess of rc-hexane was added to precipitate red powder. Purified epelmycins A, B, C, D and E were obtained with yields of 35mg, 149mg, 44mg, 27mg and 26mg, respectively. The purity of these compounds was in excess of95% as determined by HPLC,where epelmycins A, B, C, D and E had retention times of 16.0, ll.3, 4.9, 6.6 and 8.6minutes, respectively. Epelmycins are soluble in acetone, methanol, ethanol, chloroform, ethyl acetate, benzene and acidic water, but insoluble or slightly soluble in ether, hexane and water.
Structural Determination of Epelmycins The structural determination of epelmycins was mainly carried out by FD-MS, *H and 13C NMR The values were obtained on silica gel TLC, CHCl3 -MeOH (8 : 1). Table 1 . The UVand visible light ibsorption spectra of all epelmycins in 90% MeOH ;olution were similar to each other with a resemblance to e-rnodomycinone. fcpelmyans are pH Cinerulose A (CinA) Cinerulose B (CinB) indicators having a red color at neutral and acidic pH ranges while they are purple at alkaline pH. The IR absorption spectra of epelmycins indicated the presence of an ester carbonyl (1730cm" 1) and an hydrogen bonded carbonyl (1600cm"1) which are characteristic of anthracyclines.
On total acid hydrolysis followed by TLC analysis, epelmycins gave a red aglycone and the corresponding sugar components. The aglycone was identified as e-rhodomycinone from its UV, mass (m/z 428 M+) and *H and 13C NMRspectra, while the sugars were found to be rhodosamine (RN), 2-deoxyfucose (dF), cinerulose A (CinA) and cinerulose B (CinB) by a direct comparison with authentic samples (from aclacinomycins) on TLC. Results of sugar analysis are shown in Table 2 . On mild acid hydrolysis, epelmycins A, B and C gave D while E yielded C and D. Epelmycin D was composed of e-rhodomycinone and a sugar, RN and was identified as 7-0-rhodosaminyl-£-rhodomycinone consistent with a molecular formula of CsoF^NOn (m/z 585 M+) and its XHand 13C NMRspectra. These results indicate that epelmycins A, B, C and E have one or two sugars added to epelmycin D. By analogy with the sugar moiety of aclacinomycins it was inferred that epelmycins A, B, C and E had a sugar chain of RN-R-CinA, RN-dF-CinB, RN-dF and RN-dF-CinA linked to £-rhodomycinone, respectively. These data suggest the structures of the different epelmycins shown in Fig. 1 . The chemical shift assignments for the 1H and 13C NMRspectra of epelmycins were carried out by means of pulse technique, DEPT,^^H and 1H-13C COSY, and are shown in Tables 3 and 4 , respectively. In 13C NMRspectra, there is a difference in the chemical shift of C-7 between e-rhodomycinone and the corresponding aglycone moiety in epelmycin molecule. The chemical shift of C-7 was 61.8ppm for (7) 4.02 q (7) 1.39 d (7) 1.28 d (7) (7) 1.54 m (7) 1.14t (7) 3.72 s
Values were obtained in ppm (3) (/=Hz) from CDC13solutions (epelmycins) or CDC13-CD3OD (10: 1) solution (e-rhodomycinone) containing TMSas an internal reference at 400 MHz.
e-rhodomycinone and 70.6~71. 1 ppm for epelmycins. This down-field shift is attributable to a 7-0-sugar linkage as seen with other anthracyclines6). The chemical shift assignments of C-5', C-4" and C-5" of epelmycin B and C-5', C-6', C-1", C-5", C-6" and C-l'" of epelmycin E were different from those of aclacinomycin B and aclarubicin which have the same sugar chains, respectively, but others were almost identical. In epelmycins B and E, further elucidation of assignments were carried out by the correlation via long range coupling (COLOC)experiment as shown in Fig. 2 . In particular the long range coupling of C-3" with 2"'-H in epelmycin B supported the presence of an ether bond between dF and CinB. The small coupling constants (/=~4 Hz) of all anomeric protons in epelmycins indicate that the configurations of glycosidic bonds are all a.
From all these findings the structures of epelmycins were determined as illustrated in Fig. 1 . Epelmycin E was identical to CG5 which was obtained by microbial transformation7*. This is the first case of a Values were obtained in ppm (<5) from CDC13 solutions (epelmycins) or CDC13-CD3OD(10: 1) solution (e-RMN) containing TMSas an internal reference at 100 MHz.
Similar values in parentheses may be interchanged.
microbial strain producing e-rhodomycinone glycosides which contain rhodosamine, no such blocked mutant or variant strain of the aclacinomycin-producer Streptomyces galilaeus MA144-M1 has been obtained8). Epelmycins B, C, D and E have the same sugar chains in their structure as aclacinomycins B, S, T and aclarubicin, respectively.
Biological Activity The antimicrobial activities of epelmycins are shown in Table 5 . MICwas estimated by the broth-dilution method. The epelmycins exhibited antimicrobial activity against all of the Gram-positive Arrows indicate 1H-13C long range couplings. and Gram-negative bacteria tested and Candida albicans. Epelmycins were more active than aclarubicin and doxorubicin.
The cytotoxic activities of epelmycins against leukemic L1210 cell culture were examined under continuous exposure and are shown in Table 6 . The epelmycins were more potent than the aclacinomycins, doxorubicin and daunorubicin. The epelmycins exhibited a preferential inhibition of RNAsynthesis OCT. 1991 In the inhibition test for nucleic acid synthesis, the drugs were exposed for 60 minutes to L1210 cell culture (8 x 105 cells/ml) with supplemented 14C-labeled uridine or thymidine (0.05 fiCi/ml), and the incorporation of the radioisotopes into acid insoluble material was measured. For the growth inhibition test, the drugs were exposed for 48 hours to L1210 cell culture (5 x 104 cells/ml) and the viable cells were counted by coulter counter.
IC50 is expressed as a drug concentration required to inhibit by a 50%control of the growth, and DNAand RNAsyntheses of cultured L1210 cells. compared with DNAsynthesis like aclarubicin. Therefore, the epelmycins seem to belong to Class II anthracyclines in their mode of biochemical action9).
Antitumor effects in vivo of epelmycins were tested in mice bearing leukemia LI210 by daily ip administration from day 1 to 10. Epelmycins B, C, D and E had a maximum antitumor activity of 119, 179, 141 and 154% (T/C) at an optimum dose of 125, 50, 100 and 25/ig/mouse/day, respectively. Under the same conditions aclarubicin and doxorubicin had a T/C of 180 and 290%at an optimumdose of 75 and 25^g/mouse/day, respectively. The epelmycins exhibited stronger growth-inhibition activity against both microorganisms and cultured leukemic L1210 cells than aclacinomycins.
This fact suggests that a hydroxyl group at C-ll plays an important role in the biological activity.
